Working up white-matter T2/FLAIR hyperintensities

MRI

First and second year — the floor first, then every step

Location, shape and the company they keep decide it: periventricular ovoid lesions perpendicular to the ventricles, juxtacortical, infratentorial and spinal cord lesions point to demyelination; small punctate deep lesions in an older vascular patient point to small-vessel disease.

Orient first

  • White-matter hyperintensity is a sign, not a disease. The differential is broad: small-vessel disease, demyelination (MS, NMOSD, MOGAD), migraine, vasculitis, infection, toxic-metabolic.
  • MS lesions are ovoid, sit at the ventricle wall (Dawson fingers along the medullary veins), involve the corpus callosum and the U-fibres, and appear in the brainstem, cerebellum and cord.
  • Small-vessel disease spares the callosal undersurface and the U-fibres early, is symmetric and deep, and comes with lacunes and microbleeds.

Acquire the study

  • 3D FLAIR (sagittal best for the corpus callosum), axial T2, DWI, SWI, and post-contrast T1; spinal cord MRI when demyelination is suspected; the central vein sign on susceptibility-weighted FLAIR where available.

The manoeuvre

  • Count and place the lesions in the MS locations: periventricular, cortical/juxtacortical, infratentorial, spinal cord (McDonald 2017 dissemination in space: at least 1 lesion in at least 2 of 4 — verify the current revision).
  • Sagittal FLAIR: callososeptal interface lesions perpendicular to the ventricle (Dawson fingers).
  • Shape and size: ovoid over about 3 mm versus punctate or confluent.
  • Post-contrast T1: enhancing (active) and non-enhancing lesions together = dissemination in time.
  • SWI: central vein sign (favours MS) versus microbleeds (favours small-vessel or amyloid).
  • Company: lacunes, prominent perivascular spaces, age and vascular risk (small-vessel); longitudinally extensive cord lesions or area postrema lesions (NMOSD).

What confirms it

  • Demyelination: lesions in the typical locations meeting dissemination in space (and time) with no better explanation. Small-vessel disease: symmetric deep and periventricular caps and bands with lacunes in an older patient.

What licenses you to exclude it

  • A few non-specific punctate lesions do not establish MS; say so — "non-specific, most often small-vessel or migraine-related" is a legitimate conclusion.

The classic misread

  • Over-calling MS on a handful of non-specific subcortical dots.
  • Missing the corpus callosum lesions by not reading sagittal FLAIR.
  • Missing NMOSD (long cord lesion, optic neuritis, area postrema) and labelling it MS — the treatments differ.

Reference values

Each value carries the caveat that keeps it from being misused. Normal limits and diagnostic criteria are kept apart on purpose: a disease cut-off read as a normal range is the more dangerous mistake.

Diagnostic criteria

  • Cerebral white matter · White-matter hyperintensity burden — how to report it

    a named scale: Fazekas 0–3, graded separately for periventricular and deep white matter on FLAIR

    Grade against age expectation — Fazekas 1 is unremarkable in the elderly and worth comment in a 30-year-old. Confluent change (grade 3) in a young patient should prompt the demyelinating and genetic differentials, not a vascular label by default.

    MRI

  • Periventricular white matter (Dawson) · Dawson-finger morphology

    absent as a disease pattern; ovoid, perivenular, perpendicular callososeptal T2/FLAIR lesions are the MS clue, and they are not Fazekas (already registered) small-vessel dots

    Fazekas is a small-vessel grade. Dawson fingers are a morphology. Do not Fazekas an MS scan.

    MRI

See it on real cases

Direct links to Radiopaedia — the reference article and worked cases with their images. Each opens on Radiopaedia.

Key papers

Reviews and guidelines from RSNA, ESR and related journals. Each opens at its DOI.

  1. The 2024 Update to the McDonald Criteria for Multiple Sclerosis Diagnosis: A Guide for Radiologists ↗Rai P, Bathla G, Chan VEY, et al. · AJR 2026ARRS · PubMed
  2. MRI differential diagnosis of suspected multiple sclerosis ↗Chen JJ, Carletti F, Young V, et al. · Clinical Radiology 2016RCR · PubMed
  3. Central vein sign for multiple sclerosis: A systematic review and meta-analysis ↗Bhandari A, Xiang H, Lechner-Scott J, et al. · Clinical Radiology 2020RCR · PubMed
  4. Conventional and Emerging MRI Biomarkers of Multiple Sclerosis ↗Lim TR, Lim JG, Alibrahim Y, et al. · RadioGraphics 2026RSNA · PubMed
  5. MR imaging of multiple sclerosis ↗Filippi M, Rocca MA · Radiology 2011RSNA · PubMed

More searches

More in Neuro and head & neck